ID   MYO9A_HUMAN             Reviewed;        2548 AA.
AC   B2RTY4; B0I1T5; C9IYB3; C9JA86; Q14787; Q3YLD7; Q3YLD8; Q6P986; Q9H8T5;
AC   Q9NTG2; Q9NUY2; Q9UEP3; Q9UNJ2;
DT   02-SEP-2008, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 2.
DT   28-JUN-2023, entry version 134.
DE   RecName: Full=Unconventional myosin-IXa;
DE   AltName: Full=Unconventional myosin-9a;
GN   Name=MYO9A; Synonyms=MYR7;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 5), TISSUE SPECIFICITY, AND
RP   VARIANTS GLN-85; ASP-168; PRO-211; GLN-946; GLU-1193; PRO-1362 AND
RP   CYS-1834.
RX   PubMed=10409426; DOI=10.1006/geno.1999.5867;
RA   Gorman S.W., Haider N.B., Grieshammer U., Swiderski R.E., Kim E.,
RA   Welch J.W., Searby C., Leng S., Carmi R., Sheffield V.C., Duhl D.M.;
RT   "The cloning and developmental expression of unconventional myosin IXA
RT   (MYO9A) a gene in the Bardet-Biedl syndrome (BBS4) region at chromosome
RT   15q22-q23.";
RL   Genomics 59:150-160(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16572171; DOI=10.1038/nature04601;
RA   Zody M.C., Garber M., Sharpe T., Young S.K., Rowen L., O'Neill K.,
RA   Whittaker C.A., Kamal M., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Kodira C.D., Madan A., Qin S., Yang X., Abbasi N.,
RA   Abouelleil A., Arachchi H.M., Baradarani L., Birditt B., Bloom S.,
RA   Bloom T., Borowsky M.L., Burke J., Butler J., Cook A., DeArellano K.,
RA   DeCaprio D., Dorris L. III, Dors M., Eichler E.E., Engels R., Fahey J.,
RA   Fleetwood P., Friedman C., Gearin G., Hall J.L., Hensley G., Johnson E.,
RA   Jones C., Kamat A., Kaur A., Locke D.P., Madan A., Munson G., Jaffe D.B.,
RA   Lui A., Macdonald P., Mauceli E., Naylor J.W., Nesbitt R., Nicol R.,
RA   O'Leary S.B., Ratcliffe A., Rounsley S., She X., Sneddon K.M.B.,
RA   Stewart S., Sougnez C., Stone S.M., Topham K., Vincent D., Wang S.,
RA   Zimmer A.R., Birren B.W., Hood L., Lander E.S., Nusbaum C.;
RT   "Analysis of the DNA sequence and duplication history of human chromosome
RT   15.";
RL   Nature 440:671-675(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT GLU-1193.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3), AND VARIANTS
RP   LYS-37 AND GLU-1193.
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-774 (ISOFORMS 1/4).
RX   PubMed=9819351; DOI=10.1242/jcs.111.24.3597;
RA   Chieregatti E., Gaertner A., Stoeffler H.-E., Baehler M.;
RT   "Myr 7 is a novel myosin IX-RhoGAP expressed in rat brain.";
RL   J. Cell Sci. 111:3597-3608(1998).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 26-2548 (ISOFORM 1), AND VARIANT
RP   GLU-1193.
RC   TISSUE=Brain;
RA   Yamakawa H., Kikuno R.F., Nagase T., Ohara O.;
RT   "Multiplex amplification and cloning of 5'-ends of cDNA by ligase-free
RT   recombination: preparation of full-length cDNA clones encoding motor
RT   proteins.";
RL   Submitted (JAN-2007) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 234-322 (ISOFORMS 1/2/3/4).
RX   PubMed=8022818; DOI=10.1073/pnas.91.14.6549;
RA   Bement W.M., Hasson T., Wirth J.A., Cheney R.E., Mooseker M.S.;
RT   "Identification and overlapping expression of multiple unconventional
RT   myosin genes in vertebrate cell types.";
RL   Proc. Natl. Acad. Sci. U.S.A. 91:6549-6553(1994).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 292-445 (ISOFORMS 1/2/3/4/5).
RX   PubMed=16204458; DOI=10.1093/nar/gki870;
RA   Hiller M., Huse K., Platzer M., Backofen R.;
RT   "Non-EST based prediction of exon skipping and intron retention events
RT   using Pfam information.";
RL   Nucleic Acids Res. 33:5611-5621(2005).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1223-2548 (ISOFORM 4).
RC   TISSUE=Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1457-1981 (ISOFORM 4), AND
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1984-2548 (ISOFORMS 1/2/4/5).
RC   TISSUE=Ovary, and Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1299; SER-1317; SER-1364;
RP   SER-2294 AND SER-2464, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [15]
RP   PHOSPHORYLATION.
RX   PubMed=27169898; DOI=10.1038/srep25740;
RA   Lee C.P., Chiang S.L., Ko A.M., Liu Y.F., Ma C., Lu C.Y., Huang C.M.,
RA   Chang J.G., Kuo T.M., Chen C.L., Tsai E.M., Ko Y.C.;
RT   "ALPK1 phosphorylates myosin IIA modulating TNF-alpha trafficking in gout
RT   flares.";
RL   Sci. Rep. 6:25740-25740(2016).
RN   [16]
RP   INVOLVEMENT IN CMS24, AND VARIANTS CMS24 HIS-1517; GLY-1698 AND HIS-2283.
RX   PubMed=27259756; DOI=10.1093/brain/aww130;
RA   O'Connor E., Toepf A., Mueller J.S., Cox D., Evangelista T., Colomer J.,
RA   Abicht A., Senderek J., Hasselmann O., Yaramis A., Laval S.H.,
RA   Lochmueller H.;
RT   "Identification of mutations in the MYO9A gene in patients with congenital
RT   myasthenic syndrome.";
RL   Brain 139:2143-2153(2016).
RN   [17]
RP   INVOLVEMENT IN CMS24, AND VARIANTS CMS24 CYS-203 AND GLU-2282.
RX   PubMed=26752647; DOI=10.1172/jci84457;
RA   Bayram Y., Karaca E., Coban Akdemir Z., Yilmaz E.O., Tayfun G.A., Aydin H.,
RA   Torun D., Bozdogan S.T., Gezdirici A., Isikay S., Atik M.M., Gambin T.,
RA   Harel T., El-Hattab A.W., Charng W.L., Pehlivan D., Jhangiani S.N.,
RA   Muzny D.M., Karaman A., Celik T., Yuregir O.O., Yildirim T., Bayhan I.A.,
RA   Boerwinkle E., Gibbs R.A., Elcioglu N., Tuysuz B., Lupski J.R.;
RT   "Molecular etiology of arthrogryposis in multiple families of mostly
RT   Turkish origin.";
RL   J. Clin. Invest. 126:762-778(2016).
RN   [18]
RP   VARIANT CMS24 513-ARG--VAL-2548 DEL.
RX   PubMed=30237576; DOI=10.1038/s41436-018-0138-x;
RA   Maddirevula S., Alzahrani F., Al-Owain M., Al Muhaizea M.A., Kayyali H.R.,
RA   AlHashem A., Rahbeeni Z., Al-Otaibi M., Alzaidan H.I., Balobaid A.,
RA   El Khashab H.Y., Bubshait D.K., Faden M., Yamani S.A., Dabbagh O.,
RA   Al-Mureikhi M., Jasser A.A., Alsaif H.S., Alluhaydan I., Seidahmed M.Z.,
RA   Alabbasi B.H., Almogarri I., Kurdi W., Akleh H., Qari A., Al Tala S.M.,
RA   Alhomaidi S., Kentab A.Y., Salih M.A., Chedrawi A., Alameer S., Tabarki B.,
RA   Shamseldin H.E., Patel N., Ibrahim N., Abdulwahab F., Samira M., Goljan E.,
RA   Abouelhoda M., Meyer B.F., Hashem M., Shaheen R., AlShahwan S.,
RA   Alfadhel M., Ben-Omran T., Al-Qattan M.M., Monies D., Alkuraya F.S.;
RT   "Autozygome and high throughput confirmation of disease genes candidacy.";
RL   Genet. Med. 21:736-742(2019).
CC   -!- FUNCTION: Myosins are actin-based motor molecules with ATPase activity.
CC       Unconventional myosins serve in intracellular movements. Regulates Rho
CC       by stimulating it's GTPase activity in neurons. Required for the
CC       regulation of neurite branching and motor neuron axon guidance (By
CC       similarity). {ECO:0000250|UniProtKB:Q8C170,
CC       ECO:0000250|UniProtKB:Q9Z1N3}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000255}; Single-pass membrane
CC       protein {ECO:0000255}. Cytoplasm {ECO:0000250|UniProtKB:Q9Z1N3}.
CC       Synapse {ECO:0000250|UniProtKB:Q8C170}. Cell projection, growth cone
CC       {ECO:0000250|UniProtKB:Q8C170}. Note=Localized in the cytoplasm of cell
CC       bodies, dendrites and axons with occasional hints of an enrichment near
CC       the plasma membrane. Localized at the neuromuscular junction (By
CC       similarity). {ECO:0000250|UniProtKB:Q8C170,
CC       ECO:0000250|UniProtKB:Q9Z1N3}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=B2RTY4-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=B2RTY4-2; Sequence=VSP_035157;
CC       Name=3;
CC         IsoId=B2RTY4-3; Sequence=VSP_035158, VSP_035159;
CC       Name=4;
CC         IsoId=B2RTY4-4; Sequence=VSP_035160;
CC       Name=5;
CC         IsoId=B2RTY4-5; Sequence=VSP_035156;
CC   -!- TISSUE SPECIFICITY: Found to be expressed in testis and placenta and at
CC       lower levels in all the examined tissues with the exception of liver
CC       (PubMed:10409426). Isoform 5: Found in leukocytes but not in brain,
CC       retina or testis (PubMed:10409426). {ECO:0000269|PubMed:10409426}.
CC   -!- PTM: Phosphorylated by ALPK1 following monosodium urate monohydrate
CC       (MSU)-induced inflammation. {ECO:0000269|PubMed:27169898}.
CC   -!- DISEASE: Myasthenic syndrome, congenital, 24, presynaptic (CMS24)
CC       [MIM:618198]: A form of congenital myasthenic syndrome, a group of
CC       disorders characterized by failure of neuromuscular transmission,
CC       including pre-synaptic, synaptic, and post-synaptic disorders that are
CC       not of autoimmune origin. Clinical features include easy fatigability
CC       and muscle weakness. CMS24 inheritance is autosomal recessive.
CC       {ECO:0000269|PubMed:26752647, ECO:0000269|PubMed:27259756,
CC       ECO:0000269|PubMed:30237576}. Note=The disease may be caused by
CC       variants affecting the gene represented in this entry.
CC   -!- MISCELLANEOUS: [Isoform 5]: Lacks the ATP-binding domain which suggests
CC       that it cannot interact with actin. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the TRAFAC class myosin-kinesin ATPase
CC       superfamily. Myosin family. {ECO:0000305}.
CC   -!- CAUTION: Represents an unconventional myosin. This protein should not
CC       be confused with the conventional myosin-9 (MYH9). {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA91979.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=BAB14517.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF117888; AAD49195.1; -; mRNA.
DR   EMBL; AC020779; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC022872; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC090454; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC104938; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471082; EAW77880.1; -; Genomic_DNA.
DR   EMBL; BC060886; AAH60886.1; -; mRNA.
DR   EMBL; BC140869; AAI40870.1; -; mRNA.
DR   EMBL; AJ001714; CAA04947.1; -; mRNA.
DR   EMBL; AB290183; BAG06737.1; -; mRNA.
DR   EMBL; L29148; AAA20911.1; -; mRNA.
DR   EMBL; DQ088983; AAZ85978.1; -; mRNA.
DR   EMBL; DQ088984; AAZ85979.1; -; mRNA.
DR   EMBL; AL137287; CAB70679.1; -; mRNA.
DR   EMBL; AK001923; BAA91979.1; ALT_INIT; mRNA.
DR   EMBL; AK023306; BAB14517.1; ALT_INIT; mRNA.
DR   CCDS; CCDS10239.1; -. [B2RTY4-1]
DR   PIR; E59435; E59435.
DR   PIR; I61699; I61699.
DR   PIR; T46354; T46354.
DR   RefSeq; NP_008832.2; NM_006901.3. [B2RTY4-1]
DR   RefSeq; XP_006720602.1; XM_006720539.2. [B2RTY4-4]
DR   AlphaFoldDB; B2RTY4; -.
DR   SMR; B2RTY4; -.
DR   BioGRID; 110733; 94.
DR   IntAct; B2RTY4; 32.
DR   STRING; 9606.ENSP00000348349; -.
DR   GlyGen; B2RTY4; 3 sites, 1 O-linked glycan (3 sites).
DR   iPTMnet; B2RTY4; -.
DR   PhosphoSitePlus; B2RTY4; -.
DR   BioMuta; MYO9A; -.
DR   EPD; B2RTY4; -.
DR   jPOST; B2RTY4; -.
DR   MassIVE; B2RTY4; -.
DR   MaxQB; B2RTY4; -.
DR   PaxDb; B2RTY4; -.
DR   PeptideAtlas; B2RTY4; -.
DR   ProteomicsDB; 3450; -. [B2RTY4-1]
DR   ProteomicsDB; 3451; -. [B2RTY4-2]
DR   ProteomicsDB; 3452; -. [B2RTY4-3]
DR   ProteomicsDB; 3453; -. [B2RTY4-4]
DR   ProteomicsDB; 3454; -. [B2RTY4-5]
DR   Antibodypedia; 26536; 42 antibodies from 14 providers.
DR   DNASU; 4649; -.
DR   Ensembl; ENST00000356056.10; ENSP00000348349.5; ENSG00000066933.16. [B2RTY4-1]
DR   Ensembl; ENST00000424560.2; ENSP00000399162.2; ENSG00000066933.16. [B2RTY4-3]
DR   Ensembl; ENST00000444904.5; ENSP00000398250.2; ENSG00000066933.16. [B2RTY4-1]
DR   GeneID; 4649; -.
DR   KEGG; hsa:4649; -.
DR   MANE-Select; ENST00000356056.10; ENSP00000348349.5; NM_006901.4; NP_008832.2.
DR   UCSC; uc002atl.6; human. [B2RTY4-1]
DR   AGR; HGNC:7608; -.
DR   CTD; 4649; -.
DR   DisGeNET; 4649; -.
DR   GeneCards; MYO9A; -.
DR   GeneReviews; MYO9A; -.
DR   HGNC; HGNC:7608; MYO9A.
DR   HPA; ENSG00000066933; Tissue enhanced (retina).
DR   MalaCards; MYO9A; -.
DR   MIM; 604875; gene.
DR   MIM; 618198; phenotype.
DR   neXtProt; NX_B2RTY4; -.
DR   OpenTargets; ENSG00000066933; -.
DR   Orphanet; 98914; Presynaptic congenital myasthenic syndromes.
DR   PharmGKB; PA31413; -.
DR   VEuPathDB; HostDB:ENSG00000066933; -.
DR   eggNOG; KOG1453; Eukaryota.
DR   eggNOG; KOG4229; Eukaryota.
DR   GeneTree; ENSGT00940000154905; -.
DR   HOGENOM; CLU_000192_7_5_1; -.
DR   InParanoid; B2RTY4; -.
DR   OMA; KYQAANM; -.
DR   OrthoDB; 1094820at2759; -.
DR   PhylomeDB; B2RTY4; -.
DR   TreeFam; TF316834; -.
DR   PathwayCommons; B2RTY4; -.
DR   Reactome; R-HSA-8980692; RHOA GTPase cycle.
DR   Reactome; R-HSA-9013026; RHOB GTPase cycle.
DR   Reactome; R-HSA-9013424; RHOV GTPase cycle.
DR   SignaLink; B2RTY4; -.
DR   SIGNOR; B2RTY4; -.
DR   BioGRID-ORCS; 4649; 16 hits in 1152 CRISPR screens.
DR   ChiTaRS; MYO9A; human.
DR   GenomeRNAi; 4649; -.
DR   Pharos; B2RTY4; Tbio.
DR   PRO; PR:B2RTY4; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   RNAct; B2RTY4; protein.
DR   Bgee; ENSG00000066933; Expressed in calcaneal tendon and 209 other tissues.
DR   ExpressionAtlas; B2RTY4; baseline and differential.
DR   Genevisible; B2RTY4; HS.
DR   GO; GO:0044295; C:axonal growth cone; ISS:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0016020; C:membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0045202; C:synapse; IEA:UniProtKB-SubCell.
DR   GO; GO:0016461; C:unconventional myosin complex; NAS:UniProtKB.
DR   GO; GO:0051015; F:actin filament binding; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005096; F:GTPase activator activity; TAS:Reactome.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0000146; F:microfilament motor activity; IEA:InterPro.
DR   GO; GO:0034329; P:cell junction assembly; IMP:UniProtKB.
DR   GO; GO:0045198; P:establishment of epithelial cell apical/basal polarity; IMP:UniProtKB.
DR   GO; GO:0035556; P:intracellular signal transduction; IEA:InterPro.
DR   GO; GO:0043547; P:positive regulation of GTPase activity; IEA:InterPro.
DR   GO; GO:0150011; P:regulation of neuron projection arborization; ISS:UniProtKB.
DR   GO; GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome.
DR   GO; GO:0007601; P:visual perception; TAS:ProtInc.
DR   CDD; cd20883; C1_Myosin-IXa; 1.
DR   CDD; cd01385; MYSc_Myo9; 1.
DR   CDD; cd17216; RA_Myosin-IXa; 1.
DR   CDD; cd04377; RhoGAP_myosin_IX; 1.
DR   Gene3D; 1.10.10.820; -; 1.
DR   Gene3D; 1.20.5.190; -; 3.
DR   Gene3D; 1.20.58.530; -; 1.
DR   Gene3D; 3.30.60.20; -; 1.
DR   Gene3D; 6.20.240.20; -; 1.
DR   Gene3D; 3.40.850.10; Kinesin motor domain; 2.
DR   Gene3D; 1.20.120.720; Myosin VI head, motor domain, U50 subdomain; 1.
DR   Gene3D; 1.10.555.10; Rho GTPase activation protein; 1.
DR   InterPro; IPR046349; C1-like_sf.
DR   InterPro; IPR000048; IQ_motif_EF-hand-BS.
DR   InterPro; IPR036961; Kinesin_motor_dom_sf.
DR   InterPro; IPR046987; Myo9.
DR   InterPro; IPR001609; Myosin_head_motor_dom.
DR   InterPro; IPR036023; MYSc_Myo9.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR002219; PE/DAG-bd.
DR   InterPro; IPR000159; RA_dom.
DR   InterPro; IPR028558; RA_Myosin-IXa.
DR   InterPro; IPR008936; Rho_GTPase_activation_prot.
DR   InterPro; IPR000198; RhoGAP_dom.
DR   InterPro; IPR046990; RhoGAP_myosin_IX.
DR   InterPro; IPR029071; Ubiquitin-like_domsf.
DR   PANTHER; PTHR46184:SF3; UNCONVENTIONAL MYOSIN-IXA; 1.
DR   PANTHER; PTHR46184; UNCONVENTIONAL MYOSIN-IXB-LIKE PROTEIN; 1.
DR   Pfam; PF00612; IQ; 4.
DR   Pfam; PF00063; Myosin_head; 2.
DR   Pfam; PF00788; RA; 1.
DR   Pfam; PF00620; RhoGAP; 1.
DR   PRINTS; PR00193; MYOSINHEAVY.
DR   SMART; SM00109; C1; 1.
DR   SMART; SM00015; IQ; 5.
DR   SMART; SM00242; MYSc; 1.
DR   SMART; SM00314; RA; 1.
DR   SMART; SM00324; RhoGAP; 1.
DR   SUPFAM; SSF57889; Cysteine-rich domain; 1.
DR   SUPFAM; SSF48350; GTPase activation domain, GAP; 1.
DR   SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 2.
DR   SUPFAM; SSF54236; Ubiquitin-like; 1.
DR   PROSITE; PS50096; IQ; 4.
DR   PROSITE; PS51456; MYOSIN_MOTOR; 1.
DR   PROSITE; PS50200; RA; 1.
DR   PROSITE; PS50238; RHOGAP; 1.
DR   PROSITE; PS00479; ZF_DAG_PE_1; 1.
DR   PROSITE; PS50081; ZF_DAG_PE_2; 1.
PE   1: Evidence at protein level;
KW   Actin-binding; Alternative splicing; ATP-binding; Cell projection;
KW   Coiled coil; Congenital myasthenic syndrome; Cytoplasm; Disease variant;
KW   GTPase activation; Membrane; Metal-binding; Motor protein; Myosin;
KW   Nucleotide-binding; Phosphoprotein; Reference proteome; Repeat; Synapse;
KW   Transmembrane; Transmembrane helix; Zinc; Zinc-finger.
FT   CHAIN           1..2548
FT                   /note="Unconventional myosin-IXa"
FT                   /id="PRO_0000348440"
FT   TRANSMEM        175..195
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          14..112
FT                   /note="Ras-associating"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00166"
FT   DOMAIN          146..1016
FT                   /note="Myosin motor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00782"
FT   DOMAIN          1021..1041
FT                   /note="IQ 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00116"
FT   DOMAIN          1042..1071
FT                   /note="IQ 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00116"
FT   DOMAIN          1074..1103
FT                   /note="IQ 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00116"
FT   DOMAIN          1115..1144
FT                   /note="IQ 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00116"
FT   DOMAIN          1138..1167
FT                   /note="IQ 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00116"
FT   DOMAIN          2063..2251
FT                   /note="Rho-GAP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00172"
FT   ZN_FING         1999..2048
FT                   /note="Phorbol-ester/DAG-type 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00226"
FT   ZN_FING         2068..2119
FT                   /note="Phorbol-ester/DAG-type 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00226"
FT   REGION          898..920
FT                   /note="Actin-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00782"
FT   REGION          1021..1162
FT                   /note="Neck or regulatory domain"
FT   REGION          1163..2511
FT                   /note="Tail"
FT   REGION          1223..1250
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1299..1386
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1804..1836
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          2359..2383
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          2401..2424
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          2490..2531
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          1264..1291
FT                   /evidence="ECO:0000255"
FT   COILED          1486..1532
FT                   /evidence="ECO:0000255"
FT   COILED          2315..2358
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        1319..1342
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1356..1384
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1817..1831
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        2368..2383
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        2410..2424
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        2496..2510
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         239..246
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         755
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Z1N3"
FT   MOD_RES         1242
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8C170"
FT   MOD_RES         1258
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Z1N3"
FT   MOD_RES         1299
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         1317
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         1364
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         1948
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8C170"
FT   MOD_RES         2294
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         2464
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   VAR_SEQ         45..280
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:10409426"
FT                   /id="VSP_035156"
FT   VAR_SEQ         367..385
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_035157"
FT   VAR_SEQ         729
FT                   /note="H -> K (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_035158"
FT   VAR_SEQ         730..2548
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_035159"
FT   VAR_SEQ         1714
FT                   /note="E -> EVARPAHKKKARMARTRSDFLTRGTFADGEGDTEEDDYDDIIEPLLS
FT                   LDQASHCELGPAPSLGQASHSDSEM (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:17974005"
FT                   /id="VSP_035160"
FT   VARIANT         37
FT                   /note="R -> K (in dbSNP:rs17855105)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_046165"
FT   VARIANT         85
FT                   /note="R -> Q"
FT                   /evidence="ECO:0000269|PubMed:10409426"
FT                   /id="VAR_046166"
FT   VARIANT         161
FT                   /note="T -> I (in dbSNP:rs2929516)"
FT                   /id="VAR_046167"
FT   VARIANT         168
FT                   /note="N -> D"
FT                   /evidence="ECO:0000269|PubMed:10409426"
FT                   /id="VAR_046168"
FT   VARIANT         203
FT                   /note="Y -> C (in CMS24; unknown pathological significance;
FT                   dbSNP:rs374155761)"
FT                   /evidence="ECO:0000269|PubMed:26752647"
FT                   /id="VAR_081671"
FT   VARIANT         211
FT                   /note="L -> P"
FT                   /evidence="ECO:0000269|PubMed:10409426"
FT                   /id="VAR_046169"
FT   VARIANT         513..2548
FT                   /note="Missing (in CMS24; unknown pathological
FT                   significance)"
FT                   /evidence="ECO:0000269|PubMed:30237576"
FT                   /id="VAR_082148"
FT   VARIANT         825
FT                   /note="A -> V (in dbSNP:rs11637562)"
FT                   /id="VAR_056189"
FT   VARIANT         946
FT                   /note="R -> Q (in dbSNP:rs754348944)"
FT                   /evidence="ECO:0000269|PubMed:10409426"
FT                   /id="VAR_046170"
FT   VARIANT         1193
FT                   /note="G -> E (in dbSNP:rs2415129)"
FT                   /evidence="ECO:0000269|PubMed:10409426,
FT                   ECO:0000269|PubMed:15489334, ECO:0000269|Ref.3,
FT                   ECO:0000269|Ref.6"
FT                   /id="VAR_046171"
FT   VARIANT         1362
FT                   /note="S -> P (in dbSNP:rs55738821)"
FT                   /evidence="ECO:0000269|PubMed:10409426"
FT                   /id="VAR_046172"
FT   VARIANT         1476
FT                   /note="P -> R (in dbSNP:rs16956375)"
FT                   /id="VAR_046173"
FT   VARIANT         1517
FT                   /note="R -> H (in CMS24; unknown pathological significance;
FT                   dbSNP:rs149046541)"
FT                   /evidence="ECO:0000269|PubMed:27259756"
FT                   /id="VAR_081672"
FT   VARIANT         1698
FT                   /note="D -> G (in CMS24; unknown pathological significance;
FT                   dbSNP:rs150726107)"
FT                   /evidence="ECO:0000269|PubMed:27259756"
FT                   /id="VAR_081673"
FT   VARIANT         1795
FT                   /note="H -> Y (in dbSNP:rs16956367)"
FT                   /id="VAR_046174"
FT   VARIANT         1805
FT                   /note="H -> Q (in dbSNP:rs2306575)"
FT                   /id="VAR_046175"
FT   VARIANT         1834
FT                   /note="R -> C (in dbSNP:rs74475742)"
FT                   /evidence="ECO:0000269|PubMed:10409426"
FT                   /id="VAR_046176"
FT   VARIANT         2282
FT                   /note="G -> E (in CMS24; unknown pathological
FT                   significance)"
FT                   /evidence="ECO:0000269|PubMed:26752647"
FT                   /id="VAR_081674"
FT   VARIANT         2283
FT                   /note="R -> H (in CMS24; unknown pathological significance;
FT                   dbSNP:rs142345927)"
FT                   /evidence="ECO:0000269|PubMed:27259756"
FT                   /id="VAR_081675"
FT   VARIANT         2390
FT                   /note="I -> V (in dbSNP:rs2291280)"
FT                   /id="VAR_046177"
FT   CONFLICT        88
FT                   /note="L -> R (in Ref. 5; CAA04947)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        94
FT                   /note="L -> Q (in Ref. 5; CAA04947)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        104
FT                   /note="R -> H (in Ref. 5; CAA04947)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        206
FT                   /note="H -> R (in Ref. 5; CAA04947)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        394
FT                   /note="D -> N (in Ref. 5; CAA04947)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        424
FT                   /note="S -> P (in Ref. 5; CAA04947)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        504
FT                   /note="S -> C (in Ref. 5; CAA04947)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        573
FT                   /note="E -> D (in Ref. 5; CAA04947)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        595
FT                   /note="C -> Y (in Ref. 5; CAA04947)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        694
FT                   /note="I -> M (in Ref. 5; CAA04947)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        705
FT                   /note="L -> I (in Ref. 5; CAA04947)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1591
FT                   /note="S -> P (in Ref. 10; BAB14517)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   2548 AA;  292706 MW;  867835BD2B841C84 CRC64;
     MNINDGGRRR FEDNEHTLRI YPGAISEGTI YCPIPARKNS TAAEVIESLI NKLHLDKTKC
     YVLAEVKEFG GEEWILNPTD CPVQRMMLWP RMALENRLSG EDYRFLLREK NLDGSIHYGS
     LQSWLRVTEE RRRMMERGFL PQPQQKDFDD LCSLPDLNEK TLLENLRNRF KHEKIYTYVG
     SILIVINPFK FLPIYNPKYV KMYDNHQLGK LEPHIYAVAD VAYHAMLQRK KNQCIVISGE
     SGSGKTQSTN FLIHHLTALS QKGFASGVEQ IILGAGPVLE AFGNAKTAHN NNSSRFGKFI
     QVNYQETGTV LGAYVEKYLL EKSRLVYQEH NERNYHVFYY LLAGASEDER SAFHLKQPEE
     YHYLNQITKK PLRQSWDDYC YDSEPDCFTV EGEDLRHDFE RLQLAMEMVG FLPKTRRQIF
     SLLSAILHLG NICYKKKTYR DDSIDICNPE VLPIVSELLE VKEEMLFEAL VTRKTVTVGE
     KLILPYKLAE AVTVRNSMAK SLYSALFDWI VFRINHALLN SKDLEHNTKT LSIGVLDIFG
     FEDYENNSFE QFCINFANER LQHYFNQHIF KLEQEEYRTE GISWHNIDYI DNTCCINLIS
     KKPTGLLHLL DEESNFPQAT NQTLLDKFKH QHEDNSYIEF PAVMEPAFII KHYAGKVKYG
     VKDFREKNTD HMRPDIVALL RSSKNAFISG MIGIDPVAVF RWAILRAFFR AMVAFREAGK
     RNIHRKTGHD DTAPCAILKS MDSFSFLQHP VHQRSLEILQ RCKEEKYSIT RKNPRTPLSD
     LQGMNALNEK NQHDTFDIAW NGRTGIRQSR LSSGTSLLDK DGIFANSTSS KLLERAHGIL
     TRNKNFKSKP ALPKHLLEVN SLKHLTRLTL QDRITKSLLH LHKKKKPPSI SAQFQASLSK
     LMETLGQAEP YFVKCIRSNA EKLPLRFSDV LVLRQLRYTG MLETVRIRQS GYSSKYSFQD
     FVSHFHVLLP RNIIPSKFNI QDFFRKINLN PDNYQVGKTM VFLKEQERQH LQDLLHQEVL
     RRIILLQRWF RVLLCRQHFL HLRQASVIIQ RFWRNYLNQK QVRDAAVQKD AFVMASAAAL
     LQASWRAHLE RQRYLELRAA AIVIQQKWRD YYRRRHMAAI CIQARWKAYR ESKRYQEQRK
     KIILLQSTCR GFRARQRFKA LKEQRLRETK PEVGLVNIKG YGSLEIQGSD PSGWEDCSFD
     NRIKAIEECK SVIESNRISR ESSVDCLKES PNKQQERAQS QSGVDLQEDV LVRERPRSLE
     DLHQKKVGRA KRESRRMREL EQAIFSLELL KVRSLGGISP SEDRRWSTEL VPEGLQSPRG
     TPDSESSQGS LELLSYEESQ KSKLESVISD EGDLQFPSPK ISSSPKFDSR DNALSASNET
     SSAEHLKDGT MKEMVVCSSE SITCKPQLKD SFISNSLPTF FYIPQQDPLK TNSQLDTSIQ
     RNKLLENEDT AGEALTLDIN RETRRYHCSG KDQIVPSLNT ESSNPVLKKL EKLNTEKEER
     QKQLQQQNEK EMMEQIRQQT DILEKERKAF KTIEKPRIGE CLVAPSSYQS KQRVERPSSL
     LSLNTSNKGE LNVLGSLSLK DAALAQKDSS SAHLPPKDRP VTVFFERKGS PCQSSTVKEL
     SKTDRMGTQL NVACKLSNNR ISKREHFRPT QSYSHNSDDL SREGNARPIF FTPKDNMSIP
     LVSKEALNSK NPQLHKEDEP AWKPVKLAGP GQRETSQRFS SVDEQAKLHK TMSQGEITKL
     AVRQKASDSD IRPQRAKMRF WAKGKQGEKK TTRVKPTTQS EVSPLFAGTD VIPAHQFPDE
     LAAYHPTPPL SPELPGSCRK EFKENKEPSP KAKRKRSVKI SNVALDSMHW QNDSVQIIAS
     VSDLKSMDEF LLKKVNDLDN EDSKKDTLVD VVFKKALKEF RQNIFSFYSS ALAMDDGKSI
     RYKDLYALFE QILEKTMRLE QRDSLGESPV RVWVNTFKVF LDEYMNEFKT SDCTATKVPK
     TERKKRRKKE TDLVEEHNGH IFKATQYSIP TYCEYCSSLI WIMDRASVCK LCKYACHKKC
     CLKTTAKCSK KYDPELSSRQ FGVELSRLTS EDRTVPLVVE KLINYIEMHG LYTEGIYRKS
     GSTNKIKELR QGLDTDAESV NLDDYNIHVI ASVFKQWLRD LPNPLMTFEL YEEFLRAMGL
     QERKETIRGV YSVIDQLSRT HLNTLERLIF HLVRIALQED TNRMSANALA IVFAPCILRC
     PDTTDPLQSV QDISKTTTCV ELIVVEQMNK YKARLKDISS LEFAENKAKT RLSLIRRSMG
     KGRIRRGNYP GPSSPVVVRL PSVSDVSEET LTSEAAMETD ITEQQQAAMQ QEERVLTEQI
     ENLQKEKEEL TFEMLVLEPR ASDDETLESE ASIGTADSSE NLNMESEYAI SEKSERSLAL
     SSLKTAGKSE PSSKLRKQLK KQQDSLDVVD SSVSSLCLSN TASSHGTRKL FQIYSKSPFY
     RAASGNEALG MEGPLGQTKF LEDKPQFISR GTFNPEKGKQ KLKNVKNSPQ KTKETPEGTV
     MSGRRKTVDP DCTSNQQLAL FGNNEFMV
//
